Members

Sara Álvarez Morales (Technician)

Carlos Enrique Arias Cabrales (Technician)

Clara Barrios Barrera (Researcher)

David Benito Guasch (Technician)

Silvia Collado Nieto (PhD Student)

Marta Crespo Barrio (Researcher)

Anna Faura Vendrell (Technician)

Montserrat Folgueiras López (Technician)

Javier Gimeno Beltrán (Researcher)

Anna Oliveras Serrano (Researcher)

Vanesa Palau González (PhD Student)

María José Pérez Sáez (Researcher)

Marta Riera Oliva (Researcher)

Eva Rodríguez García (Technician)

Laia Sans Atxer (Researcher)

María José Soler Romeo (Researcher)

Susana Vázquez González (Researcher)

Maria Vera Casanova (Technician)

• Main Publications
• Ongoing Research Projects
• Participation in Research Networks

• Group’s Recognitions
• Clinical Trials Signed in 2016
• Theses
• Other

Main Publications

• Anguiano L, Riera M, Pascual J, Valdivielso JM, Barrios C, Betriu A, Clotet S, Mojal S, Fernández E, Soler MJ; investigators from the NEFRONA study. Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease. Atherosclerosis 2016 Oct; 253: 135-143. IF 3.99. Q1.

• Barrios C, Zierer J, Gudelj I, Stambuk J, Ugrina I, Rodríguez-García E, Soler MJ, Pavic T, Simurina M, Keser T, Pucic-Bakovic M, Mangino M, Pascual J, Spector TD, Lauc G, Menni C. Glycosylation Profile of IgG in Moderate Kidney Dysfunction. J Am Soc Nephrol 2016; 27(3): 933-941. IF 9.343. Q1.

• Clotet S, Soler MJ, Rebull M, Gimeno J, Gurley SB, Pascual J, Riera M. Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system. J Hypertens 2016; 34(9): 1752-1765. IF 5.062. Q1.

• Gimeno J, Redondo D, Pérez-Sáez MJ, Naranjo-Hans D, Pascual J, Crespo M. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction. Nephrol Dial Transplant 2016; 31(11): 1938-1946. IF 4.085. Q1.

• López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Sáez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, et al. Clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study. Am J Transplant 2016; 16(11): 3220-3224. IF 5.669. Q1.

• López-Medrano F, Silva JT, Fernández-Ruiz M, Carver PL, van Delden C, Merino E, Pérez-Sáez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín PL, et al. Risk factors associated with early invasive pulmonary aspergillosis in kidney transplant recipients: results from a multinational matched case-control study. Am J Transplant 2016; 16(7): 2148-2157. IF 5.669. Q1.

• Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sorensen SS, Hadaya K, Oberbauer R, Dudley C, de Fitjer JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, et al. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Nephrol Dial Transplant 2016; 31(6): 1002-1013. IF 4.085. Q1.

• Montero N, Pérez-Sáez MJ, Pascual J, on behalf of the DESCARTES Working Group. Immunosuppression in the elderly renal allograft recipient: a systematic review. Transplant Rev 2016; 30(3): 144-153. IF 3.915. Q1.

• O'Leary JG, Samaniego M, Crespo M, Potena L, Zeevi A, Djamali A, Cozzi E. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation 2016; 100(1): 39-53. IF 3.69. Q1.

• Oliveras A, Armario P, Clará A, Sans-Atxer L, Vázquez S, Pascual J, de la Sierra A. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. J Hypertens 2016; 34(9): 1863-1871. IF 5.062. Q1.

• Pascual J, Zuckermann A, Djamali A, Hertig A, Naesens M. Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation - A review. Transplant Rev 2016; 30(2): 85-91. IF 3.915. Q1.

• Pérez-Sáez MJ, Arcos E, Crespo M, Lloveras J, Pascual J, Catalan Renal Registry Committee. Survival benefit from kidney transplantation using kidneys from deceased donors over 75 years - a time dependent analysis. Am J Transplant 2016; 16(9): 2724-2733. IF 5.669. Q1.

• Riera M, Anguiano L, Clotet S, Roca-Ho H, Rebull M, Pascual J, Soler MJ. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Am J Physiol Renal Physiol. 2016;310(6):F534-46. I; IF 3.682. Q1.

• Segall L, Nistor I, Pascual J, Mucsi I, Guirado L, Higgins R, Van Laecke S, Oberbauer R, Van Biesen W, Abramowicz D, Gavrilovici C, Farrington K, Covic A. Criteria For And Appropriateness Of Renal Transplantation In Elderly Patients With End-Stage Renal Disease: A Literature Review And Position Statement On Behalf Of The European Renal Association-European Dialysis And Transplant Association Descartes Working Group And European Renal Best Practice. Transplantation 2016; 100(10): e55-e65. IF 3.69. Q1.

• Sekula P, Goek ON, Quaye L, Barrios C, Levey AS, Römisch-Margl W, Menni C, Yet I, Gieger C, Inker LA, Adamski J, Gronwald W, Illig T, Dettmer K, Krumsiek J, Oefner PJ, Valdes AM, Meisinger C, Coresh J, Spector TD, Mohney RP, Suhre K, Kastenmüller G, Köttgen A. A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. J Am Soc Nephrol 2016; 27(4): 1175-1188. IF 9.343. Q1.

• Van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remón C, Metcalfe W, Miguel A, Kramar R, Aasarod K, Abu Hanna A, Krediet RT, Schön S, Ravani P, Caskey F, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant 2016; 31(1): 120-128. IF 4.085. Q1.